UK markets close in 3 hours 3 minutes
  • FTSE 100

    6,661.02
    -54.40 (-0.81%)
     
  • FTSE 250

    20,604.35
    -189.37 (-0.91%)
     
  • AIM

    1,191.27
    -6.82 (-0.57%)
     
  • GBP/EUR

    1.1220
    -0.0061 (-0.54%)
     
  • GBP/USD

    1.3646
    -0.0084 (-0.61%)
     
  • BTC-GBP

    23,309.99
    +1,105.45 (+4.98%)
     
  • CMC Crypto 200

    631.98
    +21.98 (+3.60%)
     
  • S&P 500

    3,853.07
    +1.22 (+0.03%)
     
  • DOW

    31,176.01
    -12.37 (-0.04%)
     
  • CRUDE OIL

    51.62
    -1.51 (-2.84%)
     
  • GOLD FUTURES

    1,839.20
    -26.70 (-1.43%)
     
  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     
  • HANG SENG

    29,447.85
    -479.91 (-1.60%)
     
  • DAX

    13,814.53
    -92.14 (-0.66%)
     
  • CAC 40

    5,536.77
    -54.02 (-0.97%)
     

Alphabet's Verily raises $700 million in funding round

FILE PHOTO: File photo of a Google search page is seen through a magnifying glass in this photo illustration taken in Berlin

(Reuters) - Alphabet Inc's life sciences division, Verily Life Sciences LLC, said it raised $700 million in a funding round from its investors including Alphabet, Silver Lake and Temasek.

The company said it would expand its commercial businesses, Baseline and Verily Health Platforms, with the funding received.

Verily, which integrates data and technology with healthcare, had also developed a COVID-19 test, which was granted an emergency use authorization by the U.S. Food and Drug Administration in September. (https://reut.rs/34pMzl8)

(Reporting by Chavi Mehta in Bengaluru; Editing by Devika Syamnath)